Real-time monitoring of levodopa levels in Parkinson’s
Part of Brain & nervous system clinical trials.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson’s disease that meets the official “clinically established” diagnosis rules.
- You can sign consent in English or Spanish.
- Your Parkinson’s is mild to severe, and you can walk (Hoehn and Yahr stage I–IV).
- You take carbidopa/levodopa as an immediate-release pill by mouth (not another form).
- You are either not taking, or are on a stable dose of certain add-on Parkinson medicines (dopamine agonists, MAO-B inhibitors, or COMT inhibitors).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adjusting the ratio of carbidopa and levodopa (medications used for Parkinson's) can help reduce dizziness or fainting from low blood pressure when standing up, in people with Multiple System Atrophy (Parkinsonian type) or Parkinson's disease.
This study tests a new way to manage Parkinson's disease using remote monitoring technology. It aims to help you and your doctor keep track of your symptoms and adjust your care from home, improving your quality of life.
This trial tests a remote way to assess people newly diagnosed with Parkinson's disease, to help monitor their condition and guide care.
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
This study looks at how the brain's dopamine system works in people with Parkinson's disease by measuring signals from the eyes. It may help find a simple way to track the disease, which could lead to better care.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.